Why is Intuitive Surgical stock sliding today?
Intuitive Surgical (ISRG) stock fell 7.3% in after-hours trading to $406 after reporting a $450M pre-tax charge for an antitrust settlement, reducing GAAP net income to $523M ($1.49 EPS) from $704M ($1.95 EPS) YoY. Adjusted EPS beat estimates at $3.00, with revenue up 22% to $3.05B. Procedure volumes and system placements grew, but guidance remained unchanged, signaling decelerating momentum.
How this was made
The 30-second read
Why it matters
The settlement caused a sharp share decline despite strong adjusted earnings and revenue growth.
Market read
The earnings miss and settlement charge are material for ISRG and may influence med‑tech sector sentiment.
What to watch
Potential long‑term demand for da Vinci systems and instrument revenue could offset short‑term hit.
Background
Intuitive Surgical's Q3 earnings were released after market close, highlighting a large antitrust settlement charge.
Ticker impact
Intuitive Surgical reported Q3 2026 earnings with a $450M pre‑tax antitrust settlement charge, causing a 7.3% after‑hours drop to $406.
likely further decline as investors price in the GAAP earnings miss and reduced margin guidance
A sizable one‑time charge and unchanged guidance signal weaker momentum, prompting sell‑offs.
Market effects
Medical device sector may face heightened scrutiny and valuation pressure.
U.S. markets may see broader tech/healthcare sell‑off in after‑hours trading.
Limited to U.S. listed med‑tech stocks; no immediate global macro impact.
Counterpoint
Some investors may view the adjusted earnings beat and strong procedure growth as a buying opportunity if the settlement is truly one‑off.
Key entities
- CompanyIntuitive Surgical
US‑listed medical device maker of da Vinci surgical robots.

